Figure 3

Figure 3

Figure 3: AN count per patient visit (left: Mean, right: Median) until week 16 for placebo and high dose group (IFX-1 1200mg q2w). Complete case analysis, no imputation of missing values.

Format

PNG

Source

InflaRx N.V.

Downloads